Bioscience Animal Health Past Earnings Performance

Past criteria checks 5/6

Bioscience Animal Health has been growing earnings at an average annual rate of 0.8%, while the Healthcare industry saw earnings growing at 12.8% annually. Revenues have been growing at an average rate of 7.3% per year. Bioscience Animal Health's return on equity is 8.8%, and it has net margins of 2.6%.

Key information

0.8%

Earnings growth rate

-14.2%

EPS growth rate

Healthcare Industry Growth	23.6%
Revenue growth rate	7.3%
Return on equity	8.8%
Net Margin	2.6%
Last Earnings Update	30 Sep 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Bioscience Animal Health makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

THAMSE:BIS-F Revenue, expenses and earnings (THB Millions)
Date	Revenue	Earnings	G+A Expenses
30 Sep 24	2,393	63	285
30 Jun 24	2,487	62	282
31 Mar 24	2,464	58	284
31 Dec 23	2,426	51	279
30 Sep 23	2,346	48	264
30 Jun 23	2,287	45	265
31 Mar 23	2,215	45	262
31 Dec 22	2,213	56	260
30 Sep 22	2,181	60	275
30 Jun 22	2,095	66	271
31 Mar 22	2,091	77	268
31 Dec 21	1,986	72	262
30 Sep 21	1,911	75	250
31 Dec 20	1,782	62	262
31 Dec 19	1,881	30	245

Quality Earnings: BIS-F has high quality earnings.

Growing Profit Margin: BIS-F's current net profit margins (2.6%) are higher than last year (2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: BIS-F's earnings have grown by 0.8% per year over the past 5 years.

Accelerating Growth: BIS-F's earnings growth over the past year (31.6%) exceeds its 5-year average (0.8% per year).

Earnings vs Industry: BIS-F earnings growth over the past year (31.6%) exceeded the Healthcare industry 8.4%.

Return on Equity

High ROE: BIS-F's Return on Equity (8.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/28 18:56
End of Day Share Price	2024/12/27 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bioscience Animal Health Public Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution